Ardelyx (NASDAQ:ARDX) Given Strong-Buy Rating at Raymond James

Ardelyx (NASDAQ:ARDX – Get Free Report)‘s stock had its “strong-buy” rating reaffirmed by investment analysts at Raymond James in a research report issued on Friday,Benzinga reports. They currently have a $13.00 price objective on the biopharmaceutical company’s stock, down from their prior price objective of $15.00. Raymond James’ price target would suggest a potential upside […]